Md. Code, Health - General § 8-407
This is the official text of Md. Code, Health - General § 8-407, part of Maryland’s Code, Health - General — covers public health regulation.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
§8–407.
Official statutory text
(a) The Department shall identify up–to–date, evidence–based, written information about opioid use disorder that:
(1) Has been reviewed by medical experts and national and local organizations specializing in the treatment of opioid use disorder;
(2) Is designed for use by health care providers and individuals with opioid use disorder and their families;
(3) Is culturally and linguistically appropriate for potential recipients of the information; and
(4) Includes information addressing:
(i) The signs and symptoms of opioid use disorder;
(ii) The risks associated with untreated opioid use disorder;
(iii) Appropriate clinical treatment for opioid use disorder, including:
1. Counseling services; and
2. All medications approved by the U.S. Food and Drug Administration for the treatment of opioid use disorder;
(iv) Appropriate use of overdose reversal agents;
(v) Appropriate support services, including:
1. Peer fellowship and support groups, such as Narcotics Anonymous and Alcoholics Anonymous;
2. Community–based services; and
3. Residential or recovery housing services; and
(vi) Appropriate treatments for pain that may be used to reduce or replace opioid medication treatments for chronic pain.
(b) (1) The Department shall provide the information identified by the Department under subsection (a) of this section to health care facilities and health care providers that provide treatment for opioid use disorder.
(2) A health care facility or health care provider shall make the information available to each patient treated by the facility or provider for opioid use disorder.
(1) Has been reviewed by medical experts and national and local organizations specializing in the treatment of opioid use disorder;
(2) Is designed for use by health care providers and individuals with opioid use disorder and their families;
(3) Is culturally and linguistically appropriate for potential recipients of the information; and
(4) Includes information addressing:
(i) The signs and symptoms of opioid use disorder;
(ii) The risks associated with untreated opioid use disorder;
(iii) Appropriate clinical treatment for opioid use disorder, including:
1. Counseling services; and
2. All medications approved by the U.S. Food and Drug Administration for the treatment of opioid use disorder;
(iv) Appropriate use of overdose reversal agents;
(v) Appropriate support services, including:
1. Peer fellowship and support groups, such as Narcotics Anonymous and Alcoholics Anonymous;
2. Community–based services; and
3. Residential or recovery housing services; and
(vi) Appropriate treatments for pain that may be used to reduce or replace opioid medication treatments for chronic pain.
(b) (1) The Department shall provide the information identified by the Department under subsection (a) of this section to health care facilities and health care providers that provide treatment for opioid use disorder.
(2) A health care facility or health care provider shall make the information available to each patient treated by the facility or provider for opioid use disorder.
Status: in_force · Read it on the official government site
Need a lawyer in Maryland?
Find a Maryland lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.